换一批
换一批Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma.
第一作者：
Dario R,Roque
第一单位：
*Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC; †Division of Gynecologic Oncology, University of California San Diego, San Diego, CA; ‡Division of Gynecologic Oncology, Washington University, St Louis, MO; §Madigan Army Medical Center, Tacoma, WA; and ∥Program in Women's Oncology, Women & Infants Hospital; and ¶Division of Research, Women & Infants Hospital, Providence, RI.
作者：
主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);化学疗法, 辅助(Chemotherapy, Adjuvant);脱氧胞苷(Deoxycytidine);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);平滑肌肉瘤(Leiomyosarcoma);肿瘤侵润(Neoplasm Invasiveness);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);预后(Prognosis);放射疗法, 辅助(Radiotherapy, Adjuvant);回顾性研究(Retrospective Studies);存活率(Survival Rate);紫杉烷类(Taxoids);子宫肿瘤(Uterine Neoplasms)
DOI
10.1097/IGC.0000000000000634
PMID
26807641
发布时间
2022-12-07
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
